| Company Name: | NCE Biomedical Co.,Ltd. Gold |
| Tel: | 4000-027-021 |24 hour enquiry :+86-13986109188 |English:+86-15623472865 |Japanese:+81-08033611988 |
| Email: | sales@ncebiomed.com |
| Products Intro: |
Product Name:TAK-875
CAS:1000413-72-8
Purity:99% HPLC Package:50Mg,100Mg,500Mg,1g,5g,10g,50g,100g,500g,1kg Remarks:XYA0027 |
| Company Name: | DongGuan WaliXi Chemical Co., Ltd. Gold |
| Tel: | 13352886872 |
| Email: | 1489577060@qq.com |
| Products Intro: |
Product Name:TAK-875
CAS:1000413-72-8
Purity:98% Package:50Mg,100Mg,500Mg,1g,5g,10g,50g,100g,500g |
| Company Name: | Shanghai Send Pharmaceutical Co., Ltd. Gold |
| Tel: | 021-50266790 13585868794 QQ2635253576, 2086672224 |
| Email: | sale@shsendpharm.com |
| Products Intro: |
Product Name:TAK875
CAS:1000413-72-8
Purity:98% HPLC Package:1g,5g,10g…1kg,5kg,10kg |
| Company Name: | Shanghai Boyle Chemical Co., Ltd. |
| Tel: | Mr Qiu 86-21-50182298(Domestic Market)Miss Xu 86-21-50180596(Abroad Market) |
| Email: | sales@boylechem.com |
| Products Intro: |
Product Name:TAK875
CAS:1000413-72-8
|
| Company Name: | J & K SCIENTIFIC LTD. |
| Tel: | 400-666-7788 +86-10-82848833 |
| Email: | jkinfo@jkchemical.com;market3@jkchemical.com |
| Products Intro: |
Product Name:TAK-875
CAS:1000413-72-8
Package:10Mg,200Mg,50Mg,5Mg |
|
| Product Name: | TAK875 | | Synonyms: | TAK875;3-Benzofuranacetic acid, 6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-, (3S)-;(3S)-6-[[2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic acid;TAK-875,TAK875;[(3S)-6-({2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy]-3-biphenylyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid;(S)-2-(6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid | | CAS: | 1000413-72-8 | | MF: | C29H32O7S | | MW: | 524.62518 | | EINECS: | -0 | | Product Categories: | | | Mol File: | 1000413-72-8.mol |  |
| | TAK875 Chemical Properties |
| | TAK875 Usage And Synthesis |
| Usage | TAK-876 is a selective G protein-coupled receptor 40 (GPR40) agonist. TAK-876 is a novel oral medication that has been developed to improve the secretion of insulin in a glucose-dependent manner, whic
h has the potential to improve the control of blood sugar levels without the risk of hypoglycemia. |
| | TAK875 Preparation Products And Raw materials |
|